Clinical Trials Logo
  1. Home
  2. Premature Infants
  3. NCT03914690

Effect of Erythropoietin on Neurodevelopmental Outcomes in Very Preterm Infants With Intraventricular Hemorrhage

Premature Infants Clinical Trial

Official title:
Effect of Erythropoietin on Neurodevelopmental Outcomes in Very Preterm Infants With Intraventricular Hemorrhage

Clinical Trial Summary

Erythropoietin (EPO) has been shown to be neurotrophic and neuroprotective in several animal models and some clinical studies. Our hypothesis is that EPO could improve long-term neurological outcomes in very preterm infants with intraventricular hemorrhage (IVH). The aim of this study is to evaluate the long-term neuroprotective effect of repeated low-dose EPO (500 U/kg) in very preterm infants with IVH.

Clinical Trial Description

IVH is one of the most common complications in preterm infants. Nearly 60% of preterm infants with grade III-IV IVH develop severe neurodevelopmental outcomes. There are currently no effective treatments to prevent preterm infants with IVH from developing ventricular dilation or serious neurological disabilities. Recent studies have shown that EPO could improve neurodevelopmental outcomes in preterm infants with grade III-IV IVH. However, the dose and course of EPO in preterm infants is still uncertain. The purpose of the study was whether repeated low-dose EPO (500 U/kg, every other day, for 2 weeks) given to very preterm right after the diagnosis of IVH could improve long-term neurological outcomes. Very preterm infants with gestational age of ≤ 32 weeks who are diagnosed with IVH within 72 hours after birth in NICU are eligible for enrolment. After informed consent is obtained, infants will be randomly assigned to EPO group or vehicle group. The primary outcome is whether EPO improves mortality and neurological disabilities in very preterm infants with IVH at 18 months of corrected age, and the secondary outcome was whether EPO decrease the incidence of cerebral palsy, MDI<70, blindness, and deafness. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03914690
Study type Interventional
Source Zhengzhou University
Contact
Status Completed
Phase Phase 2
Start date July 2014
Completion date July 2019
View Details
See also
  Status Clinical Trial Phase
Completed NCT02785926 - Impact of Antenatal Exposure to Pesticides on Neurophysiological Functions (Sleep, Respiration) of Preterm Neonates
Completed NCT01946971 - Lansoprazole in Preterm Infants With Gastroesophageal Reflux (GER) Phase 1/Phase 2
Completed NCT01530360 - Cerebral Oxygenation to Guide Medical Interventions in Extremely Preterm Infants Phase 1
Completed NCT00681018 - Feeding Study in Premature Infants N/A
Completed NCT00217191 - Ibuprofen and Renal Function in Premature Infants Phase 4
Completed NCT01077271 - Compliance to Synagis (Palivizumab) Under Daily Pediatrician´s Conditions in Premature Infants 33 - 35 wGA N/A
Completed NCT00282113 - Effects of Probiotic and Prebiotic Combinations on Premature Infants N/A
Active, not recruiting NCT02943746 - Targeted Protein Fortification in Extremely Low Birth Weight Preterm Infants N/A
Completed NCT01994954 - A Randomized Trial of Outpatient Oxygen Weaning Strategies in Premature Infants N/A
Completed NCT00389909 - Dosing Chart for Calculating the First Dose of Doxapram in Premature Infants Phase 4
Completed NCT00747591 - Urine Concentration of S100B in Extremely Premature Infants N/A
Recruiting NCT04555590 - Implementation of an Evidence Based Parentally Administered Intervention for Preterm Infants N/A
Completed NCT06352047 - The Effects of Positioning After Extubation of Preterm Infants on the Respiratory Functions N/A
Completed NCT03217045 - Nutrition Protocol and Premature Infants' Growth
Recruiting NCT03552952 - Development of Preterm Infant Gut Microbiome
Recruiting NCT06332521 - Infant Crying, a Bioacoustic Prognostic Signal for Neurodevelopment
Completed NCT04659083 - How NAVA Works in Preterm Infants With Irregular Respiratory Efforts
Completed NCT05807191 - The Effect of Using Clinical Guidelines on Kangaroo Care on Newborn and Maternal Outcomes N/A
Completed NCT01140243 - Infant Formula Supplemented With a Special Fat Formulation for Premature Infants Following Discharge From Hospital N/A
Completed NCT00957840 - Intraventricular Hemorrhage and Post Hemorrhagic Ventricular Dilation: Natural Course, Treatment, and Outcome N/A